Hydrochloric Acid

Hydrochloric Acid

SCHEMBL6885887

CCCCC1=Cc2c(-c3cccc4ccccc34)cccc2C1[Zr+2]1(C2C(CCCC)=Cc3c(-c4cccc5ccccc45)cccc32)C2CCCCC21.[Cl-].[Cl-]

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 0.35
SLC6A4 P31645 2/20 0.33
HTR7 P34969 1/20 0.33
DRD2 P14416 1/20 0.33
CNR1 P21554 2/20 0.33
CNR2 P34972 1/20 0.32
DPP4 P27487 1/20 0.31
TLR8 Q9NR97 1/20 0.30
ALOX15 P16050 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6894289 0.94 SLC6A4 (0.34) BCHESLC6A4HTR7DRD2
Hydrochloric Acid SCHEMBL6889900 0.89 SLC6A4 (0.33) SLC6A4HTR7DRD2
Hydrochloric Acid SCHEMBL6894050 0.89 BCHE (0.37) BCHESLC6A4DRD2CNR1DPP4
Hydrochloric Acid SCHEMBL6891400 0.89 HTR1A (0.35) BCHEHTR7
Hydrochloric Acid SCHEMBL6892319 0.86 SLC6A4 (0.34) BCHESLC6A4HTR7DRD2CNR1
Hydrochloric Acid SCHEMBL6892296 0.86 HTR1A (0.30) HTR7
Hydrochloric Acid SCHEMBL5951387 0.86 SLC6A4 (0.35) BCHESLC6A4HTR7DRD2CNR1
Hydrochloric Acid SCHEMBL6889711 0.84 NPC1 (0.31) HTR7
Hydrochloric Acid SCHEMBL6889799 0.82 HTR1A (0.36) SLC6A4HTR7DRD2
Hydrochloric Acid SCHEMBL6893651 0.82 KDM4E (0.37) BCHESLC6A4HTR7DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6784305-B2 DERIVATIVES OF ZIRCONOCENE DICHLORIDE IN WHICH THE TWO SUBSTITUTED INDENYL GROUPS ARE JOINED TO ONE ANOTHER VIA A BRIDGE CAN, OWING TO THEIR CONFORMATIONAL RIGIDITY, BE USED AS CATALYSTS FOR THE STEREOSPECIFIC POLYMERIZATION OF OLEFINS BASELL POLYOLEFINE GMBH (DE) 2004-08-31 US disclosed
US-20030199703-A1 Method for producing alkyl-bridged ligand systems and transition metal compounds EQUISTAR CHEMICALS, LP 2003-10-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030199703-A1 Method for producing alkyl-bridged ligand systems and transition metal compounds ABL1, ICMT, ORAI2 BCHE 4132/4885SLC6A4 1973/4885HTR7 3115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.